Mihael Hristos Polymeropoulos Vanda Pharmaceuticals Inc. (VNDA) insider trading activity

VNDA Quotes by TradingView

Mihael Hristos Polymeropoulos is President and CEO of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 2.33 Million shares of VNDA, which is worth approximately $10.5 Million. The most recent transaction as insider was on Dec 01, 2021, when has been sold 71,676 shares (Common Stock) at a price of $4.88 per share, resulting in proceeds of $349,779. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.33M
1.31% 3M change
24.26% 12M change
Total Value Held $10.5 Million

Mihael Hristos Polymeropoulos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2021
BUY
Exercise of conversion of derivative security
$349,779 $4.88 p/Share
71,676 Added 5.15%
1,321,062 Common Stock
Nov 30 2021
SELL
Open market or private sale
$824,500 $16.49 p/Share
50,000 Reduced 3.85%
1,249,386 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
$382,221 $4.88 p/Share
78,324 Added 5.69%
1,299,386 Common Stock
Mar 08 2021
SELL
Open market or private sale
$3,150,000 $18.0 p/Share
175,000 Reduced 12.54%
1,221,062 Common Stock
Mar 02 2021
SELL
Open market or private sale
$278,878 $18.34 p/Share
15,206 Reduced 1.08%
1,396,062 Common Stock
Mar 01 2021
SELL
Open market or private sale
$137,988 $18.45 p/Share
7,479 Reduced 0.53%
1,411,268 Common Stock
Feb 24 2021
BUY
Grant, award, or other acquisition
-
115,000 Added 7.5%
1,418,747 Common Stock
Dec 15 2020
SELL
Open market or private sale
$508,950 $13.0 p/Share
39,150 Reduced 2.92%
1,303,747 Common Stock
Dec 15 2020
BUY
Exercise of conversion of derivative security
$408,301 $8.75 p/Share
46,663 Added 3.36%
1,342,897 Common Stock
Dec 14 2020
SELL
Open market or private sale
$673,336 $13.19 p/Share
51,049 Reduced 3.79%
1,296,234 Common Stock
Dec 14 2020
BUY
Exercise of conversion of derivative security
$538,300 $8.75 p/Share
61,520 Added 4.37%
1,347,283 Common Stock
Dec 11 2020
SELL
Open market or private sale
$451,483 $12.88 p/Share
35,053 Reduced 2.65%
1,285,763 Common Stock
Dec 11 2020
BUY
Exercise of conversion of derivative security
$365,899 $8.75 p/Share
41,817 Added 3.07%
1,320,816 Common Stock
MHP

Mihael Hristos Polymeropoulos

President and CEO
Washington, DC

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on VNDA